{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:31:08Z","timestamp":1793053868389,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017683","name":"Frederick A. DeLuca Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["CA-016359"],"award-info":[{"award-number":["CA-016359"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008483","name":"NOMIS Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010900","name":"Yale University Yale Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jval.2025.09.3064","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:55:41Z","timestamp":1760536541000},"page":"946-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Threshold Inequality Aversion Parameter Approach to Interpret Distributional Cost-Effectiveness Analysis Results"],"prefix":"10.1016","volume":"29","author":[{"given":"Ankur","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Luviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndon P.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Goshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jval.2025.09.3064_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJM197703312961304","article-title":"Foundations of cost-effectiveness analysis for health and medical practices","volume":"296","author":"Weinstein","year":"1977","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3064_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X15583266","article-title":"Distributional cost-effectiveness analysis: a tutorial","volume":"36","author":"Asaria","year":"2016","journal-title":"Med Decis Making"},{"issue":"6","key":"10.1016\/j.jval.2025.09.3064_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/M22-3272","article-title":"Distributional cost-effectiveness of equity-enhancing gene therapy in sickle cell disease in the United States","volume":"176","author":"Goshua","year":"2023","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jval.2025.09.3064_bib4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40273-023-01276-5","article-title":"Cost effectiveness of strategies to manage atrial fibrillation in middle- and high-income countries: a systematic review","volume":"41","author":"Okafor","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"12 suppl","key":"10.1016\/j.jval.2025.09.3064_bib5","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.cjco.2021.09.004","article-title":"Racial and ethnic differences in the management of atrial fibrillation","volume":"3","author":"Tamirisa","year":"2021","journal-title":"CJC Open"},{"issue":"6","key":"10.1016\/j.jval.2025.09.3064_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jval.2023.02.006","article-title":"Eliciting trade-offs between equity and efficiency: a methodological scoping review","volume":"26","author":"Cadham","year":"2023","journal-title":"Value Health"},{"issue":"1\/2","key":"10.1016\/j.jval.2025.09.3064_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2307\/1913738","article-title":"Risk aversion in the small and in the large","volume":"32","author":"Pratt","year":"1964","journal-title":"Econometrica"},{"issue":"2 suppl","key":"10.1016\/j.jval.2025.09.3064_bib8","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making"},{"issue":"12","key":"10.1016\/j.jval.2025.09.3064_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2025.01.005","article-title":"Using distributional cost-effectiveness analysis to improve equity and efficiency","volume":"85","author":"Goshua","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jval.2025.09.3064_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2022.102643","article-title":"Prevention, treatment, and palliative care: the relative value of health improvements under alternative evaluation frameworks","volume":"84","author":"Hammitt","year":"2022","journal-title":"J Health Econ"},{"key":"10.1016\/j.jval.2025.09.3064_bib11","series-title":"Multidimensional Inequality: Measurement and Analysis Using the American Community Survey. SEHSD Working Paper Number 2019-17, US Census Bureau","author":"Glassman","year":"2019"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3064_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0022-0531(70)90039-6","article-title":"On the measurement of inequality","volume":"2","author":"Atkinson","year":"1970","journal-title":"J Econ Theor"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3064_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0022-0531(76)90037-5","article-title":"Unequal inequalities","volume":"12","author":"Kolm","year":"1976","journal-title":"J Econ Theor"},{"key":"10.1016\/j.jval.2025.09.3064_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2147\/CEOR.S471827","article-title":"Health equity considerations in cost-effectiveness analysis: insights from an umbrella review","volume":"16","author":"Muir","year":"2024","journal-title":"Clinicoecon Outcomes Res"},{"issue":"7","key":"10.1016\/j.jval.2025.09.3064_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0277-9536(97)00044-0","article-title":"The relationship of income inequality to mortality: does the choice of indicator matter?","volume":"45","author":"Kawachi","year":"1997","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.jval.2025.09.3064_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1539-6924.2008.01119.x","article-title":"Evaluating efficiency-equality tradeoffs for mobile source control strategies in an urban area","volume":"29","author":"Levy","year":"2009","journal-title":"Risk Anal"},{"issue":"15","key":"10.1016\/j.jval.2025.09.3064_bib17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.2023.1792","article-title":"Cost-effectiveness thresholds used by study authors, 1990-2021","volume":"329","author":"Neumann","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jval.2025.09.3064_bib18","series-title":"Decision Making in Health and Medicine: Integrating Evidence and Values","first-page":"267","article-title":"Chapter 9.6. Incremental cost-effectiveness analysis","author":"Hunink","year":"2014"},{"key":"10.1016\/j.jval.2025.09.3064_bib19","author":"Cropper"},{"issue":"5","key":"10.1016\/j.jval.2025.09.3064_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0277-9536(02)00107-7","article-title":"Trends in the association between average income, poverty and income inequality and life expectancy in Spain","volume":"56","author":"Regidor","year":"2003","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.jval.2025.09.3064_bib21","first-page":"239","article-title":"Measuring multidimensional inequality and well-being: methods and an empirical application to Italian","volume":"71","author":"Aristei","year":"2011","journal-title":"Statistica"},{"key":"10.1016\/j.jval.2025.09.3064_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2019.102276","article-title":"Inequality aversion in income, health, and income-related health","volume":"70","author":"Hurley","year":"2020","journal-title":"J Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2025.09.3064_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40258-018-0394-6","article-title":"Inference procedures to quantify the efficiency-equality trade-off in health from stated preferences: a case study in Portugal","volume":"16","author":"Pinho","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.jval.2025.09.3064_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2024.102856","article-title":"Aversion to health inequality - pure, income-related and income-caused","volume":"94","author":"Robson","year":"2024","journal-title":"J Health Econ"},{"issue":"12","key":"10.1016\/j.jval.2025.09.3064_bib25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hec.1799","article-title":"Public preferences for responsibility versus public preferences for reducing inequalities","volume":"21","author":"Edlin","year":"2012","journal-title":"Health Econ"},{"issue":"8","key":"10.1016\/j.jval.2025.09.3064_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40273-020-00915-5","article-title":"Why it\u2019s Time to Abandon the ICER","volume":"38","author":"Paulden","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2025.09.3064_bib27","doi-asserted-by":"crossref","unstructured":"Cookson R. (2023). Distributional cost-effectiveness: putting money where your mouth is on health equity. Ann Int Med. 2023;176(6):866-7.","DOI":"10.7326\/M23-1145"},{"key":"10.1016\/j.jval.2025.09.3064_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2024.117495","article-title":"Aversion to income, ethnic, and geographic related health inequality: evidence from Australia","volume":"364","author":"Boujaoude","year":"2025","journal-title":"Soc Sci Med"},{"issue":"18","key":"10.1016\/j.jval.2025.09.3064_bib29","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1080\/00036840903166244","article-title":"Determining the parameters in a social welfare function using stated preference data: an application to health","volume":"43","author":"Dolan","year":"2011","journal-title":"Appl Econ"},{"issue":"5","key":"10.1016\/j.jval.2025.09.3064_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40273-021-01123-5","article-title":"Cost-effectiveness risk-aversion curves: comparison of risk-adjusted performance measures and expected-utility approaches","volume":"40","author":"Elbasha","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.jval.2025.09.3064_bib31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/healthcare9111419","article-title":"Handling uncertainty in cost-effectiveness analysis: budget impact and risk aversion","volume":"9","author":"Sendi","year":"2021","journal-title":"Healthcare (Basel)"},{"issue":"6","key":"10.1016\/j.jval.2025.09.3064_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1177\/0272989X211009883","article-title":"Uncertainty analysis in intervention impact on health inequality for resource allocation decisions","volume":"41","author":"Yang","year":"2021","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.jval.2025.09.3064_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-6296(98)00039-3","article-title":"The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies","volume":"18","author":"Claxton","year":"1999","journal-title":"J Health Econ"},{"key":"10.1016\/j.jval.2025.09.3064_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1472-6963-6-52","article-title":"Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation","volume":"6","author":"Fenwick","year":"2006","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.1016\/j.jval.2025.09.3064_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40273-020-00915-5","article-title":"\u201cWhy it's Time to Abandon the ICER.\u201d","volume":"38","author":"Paulden","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2025.09.3064_bib36","doi-asserted-by":"crossref","DOI":"10.7326\/M23-1145","article-title":"\u201dDistributional Cost-Effectiveness: Putting Money Where Your Mouth Is on Health Equity.\u201d","author":"Cookson","year":"2023","journal-title":"Annals of internal medicine"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525056219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525056219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:29:29Z","timestamp":1782512969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525056219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1098301525056219"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.09.3064","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Threshold Inequality Aversion Parameter Approach to Interpret Distributional Cost-Effectiveness Analysis Results","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.09.3064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}